Pretreatment HPV16 ct-DNA was detected in 71% of patients, in which this baseline level positively correlated with T and N status and a positive trend for the M status.
← all excerpts
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives.
1
—
—